These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31796216)

  • 1. New imidazolone derivatives comprising a benzoate or sulfonamide moiety as anti-inflammatory and antibacterial inhibitors: Design, synthesis, selective COX-2, DHFR and molecular-modeling study.
    Metwally NH; Mohamed MS
    Bioorg Chem; 2020 Jun; 99():103438. PubMed ID: 31796216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
    Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA
    Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
    Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
    Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF; Philoppes JN; Rárová L
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and anti-inflammatory assessment of certain substituted 1,2,4-triazoles bearing tetrahydroisoquinoline scaffold as COX 1/2-inhibitors.
    Abo-Elmagd MI; Hassan RM; Aboutabl ME; Amin KM; El-Azzouny AA; Aboul-Enein MN
    Bioorg Chem; 2024 Sep; 150():107577. PubMed ID: 38941697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
    Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors.
    Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC
    Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
    Kumar R; Saha N; Purohit P; Garg SK; Seth K; Meena VS; Dubey S; Dave K; Goyal R; Sharma SS; Banerjee UC; Chakraborti AK
    Eur J Med Chem; 2019 Nov; 182():111601. PubMed ID: 31445233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies.
    Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH
    Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
    Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
    Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
    Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in-vitro, in-vivo anti-inflammatory activities and molecular docking studies of acyl and salicylic acid hydrazide derivatives.
    Munir A; Khushal A; Saeed K; Sadiq A; Ullah R; Ali G; Ashraf Z; Ullah Mughal E; Saeed Jan M; Rashid U; Hussain I; Mumtaz A
    Bioorg Chem; 2020 Nov; 104():104168. PubMed ID: 32947133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluations of novel isoxazoles and furoxan derivative as anti-inflammatory agents.
    Abdelall EKA
    Bioorg Chem; 2020 Jan; 94():103441. PubMed ID: 31859011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
    Grover J; Kumar V; Sobhia ME; Jachak SM
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new pyrazoles and pyrozolo [3,4-b] pyridines as anti-inflammatory agents by inhibition of COX-2 enzyme.
    Mohamed LW; Shaaban MA; Zaher AF; Alhamaky SM; Elsahar AM
    Bioorg Chem; 2019 Mar; 83():47-54. PubMed ID: 30342385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring of novel oxazolones and imidazolones as anti-inflammatory and analgesic candidates with cyclooxygenase inhibitory action.
    Rayan SA; George RF; Mohamed NM; Said MF
    Future Med Chem; 2024; 16(10):963-981. PubMed ID: 38639393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
    Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
    Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
    Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
    Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.